Literature DB >> 7638572

Expression of tumour necrosis factor-alpha, interleukin-6, and interleukin-2 mRNA in the jejunum of patients with coeliac disease.

M Kontakou1, R T Przemioslo, R P Sturgess, A G Limb, P J Ciclitira.   

Abstract

BACKGROUND: A T-cell-mediated immune response may be responsible for the enteropathy seen in coeliac disease (CD), but it is unclear whether this is initiated in the epithelium or the lamina propria. We studied the site and number of cells expressing mRNA encoding the cytokines interleukin-2 (IL-2), IL-6, and tumour necrosis factor-alpha in jejunal biopsy specimens from patients with untreated or treated CD and normal controls.
METHODS: Tissue sections were hybridized with 35S-labelled DNA oligonucleotide probes specific for each cytokine RNA sequence. Positive cells were counted in the lamina propria and epithelial compartments.
RESULTS: For each cytokine significantly greater numbers of positive cells were found in the lamina propria of untreated CD patients. Few positive cells were detected in the epithelium of all three groups.
CONCLUSIONS: This study shows that the immune response to gliadin appears to occur in the lamina propria and supports cell-mediated immunity in the pathogenesis of coeliac disease.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7638572     DOI: 10.3109/00365529509093307

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  19 in total

1.  Intravitreal invading cells contribute to vitreal cytokine milieu in proliferative vitreoretinopathy.

Authors:  I A El-Ghrably; H S Dua; G M Orr; D Fischer; P J Tighe
Journal:  Br J Ophthalmol       Date:  2001-04       Impact factor: 4.638

Review 2.  Recent advances in the understanding of celiac disease: therapeutic implications for the management of pediatric patients.

Authors:  John H Kwon; Richard J Farrell
Journal:  Paediatr Drugs       Date:  2006       Impact factor: 3.022

3.  Analysis of interleukin-4 and interleukin-10 and their association with the lymphocytic infiltrate in the small intestine of patients with coeliac disease.

Authors:  C G Beckett; D Dell'Olio; M Kontakou; R T Przemioslo; S Rosen-Bronson; P J Ciclitira
Journal:  Gut       Date:  1996-12       Impact factor: 23.059

Review 4.  Effector and suppressor T cells in celiac disease.

Authors:  Giuseppe Mazzarella
Journal:  World J Gastroenterol       Date:  2015-06-28       Impact factor: 5.742

5.  Avenin fails to induce a Th1 response in coeliac tissue following in vitro culture.

Authors:  C Kilmartin; S Lynch; M Abuzakouk; H Wieser; C Feighery
Journal:  Gut       Date:  2003-01       Impact factor: 23.059

6.  Expression of interleukin-4 and interferon-gamma in the small bowel of patients with dermatitis herpetiformis and isolated gluten-sensitive enteropathy.

Authors:  A D Smith; B Bagheri; R D Streilein; R P Hall
Journal:  Dig Dis Sci       Date:  1999-10       Impact factor: 3.199

7.  Inflammatory cytokines in small intestinal mucosa of patients with potential coeliac disease.

Authors:  M Westerholm-Ormio; J Garioch; I Ketola; E Savilahti
Journal:  Clin Exp Immunol       Date:  2002-04       Impact factor: 4.330

8.  The role of NF-kappaB, IRF-1, and STAT-1alpha transcription factors in the iNOS gene induction by gliadin and IFN-gamma in RAW 264.7 macrophages.

Authors:  Daniela De Stefano; Maria Chiara Maiuri; Barbara Iovine; Armando Ialenti; Maria Assunta Bevilacqua; Rosa Carnuccio
Journal:  J Mol Med (Berl)       Date:  2005-11-12       Impact factor: 4.599

Review 9.  Evaluation and management of skeletal health in celiac disease: position statement.

Authors:  Mona A Fouda; Aliya A Khan; Muhammad Saad Sultan; Lorena P Rios; Karen McAssey; David Armstrong
Journal:  Can J Gastroenterol       Date:  2012-11       Impact factor: 3.522

10.  Gliadin increases iNOS gene expression in interferon-gamma-stimulated RAW 264.7 cells through a mechanism involving NF-kappa B.

Authors:  Maria Chiara Maiuri; Daniela De Stefano; Guido Mele; Barbara Iovine; Maria Assunta Bevilacqua; Luigi Greco; Salvatore Auricchio; Rosa Carnuccio
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-07-04       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.